Comparative efficacy of different chemotherapies for non-Hodgkin lymphoma: a network-meta analysis.

about

Comparative efficacy of different chemotherapies for non-Hodgkin lymphoma: a network-meta analysis.

Item

http://www.wikidata.org/entity/Q47154491

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Comparative efficacy of differ ...... homa: a network-meta analysis.

@en

Comparative efficacy of differ ...... homa: a network-meta analysis.

@nl

type

Item

label

Comparative efficacy of differ ...... homa: a network-meta analysis.

@en

Comparative efficacy of differ ...... homa: a network-meta analysis.

@nl

prefLabel

Comparative efficacy of differ ...... homa: a network-meta analysis.

@en

Comparative efficacy of differ ...... homa: a network-meta analysis.

@nl

P1476

Comparative efficacy of differ ...... homa: a network-meta analysis.

@en

P2093

Dan Wang

http://www.w3.org/2001/XMLSchema#string

Jiawei Xu

http://www.w3.org/2001/XMLSchema#string

Jinjin Hao

http://www.w3.org/2001/XMLSchema#string

Pengcheng Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions for previously untreated patients with AIDS-associated Non-Hodgkin´s Lymphoma

Cancer statistics, 2015

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma

Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

P304

91238-91247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20437

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29207639

http://www.w3.org/2001/XMLSchema#string

P932

5710919

http://www.w3.org/2001/XMLSchema#string